-
Nursing Leaders Warn HSE Recruitment Controls Are Unsafe
-
Miranda Lambert Leads North Texans with Seven Grammy Nominations for 2027
-
Son Suk-ku and Eita Nagayama Star in Netflix’s 'The Blue Road' Cross-Border Crime Thriller
-
DiDi Advances Robotaxi Operations in China with New R2 Vehicle and Expanded Safety Infrastructure
-
Moving to a New State? Your Healthcare Might Get More Complicated
-
Smart Car Seats Tested: Do Sensors and Apps Actually Improve Safety?
-
South Africa’s Economic Shift: Why Services Must Lead Job Creation Beyond Manufacturing
-
5 Strategies for Fort Worth Households to Reduce Summer Electricity Costs
-
Lethbridge Council to Vote on $80 Million Capital Improvement Program
-
Central Bank of Malta Links Energy Subsidies to Middle East Conflict and Price Volatility
-
Redmi Note 18 5G Battery Specs Leaked: Larger Capacity in Chinese Variant
-
Shomari Figures Defies Redistricting in Alabama Amid Disaster Relief Crisis
-
COP31 Presidency Publishes First Draft Cover Decision on Climate Action
-
BYD Dolphin G Leasing Deal: Plug-in Hybrid Supermini Available from £174 a Month
-
EU Club Group Files Antitrust Complaint Against UEFA Over Prize Money
-
Egypt Opens Registration for 2027 Total Solar Eclipse Viewing Packages
-
Heat and El Niño Drive Surge in Preterm Births Across Southern Africa
-
French Economy Shrinks 0.1% as Consumer Confidence Slumps
-
China's Factory Activity Contracts as Export Orders Weaken
-
Wall Street Ends Turbulent Week Higher Despite Inflation and AI Jitters
-
US Retail Sales and Fed Minutes Set Up a Critical Test for Consumers
-
Kansas City Fed Chief Says Inflation Is Still Running Too Hot
-
Oil Heads for Second Weekly Loss as Supply Surplus Emerges
-
Asian Markets Slide as AI Concerns Hit Chip Stocks
-
Brazil Faces Debt and Inflation Test as Lula Prepares Fourth Term
-
Tom Brady’s Viral Reaction to Deebo Samuel’s Trick-Play Touchdown
-
Canada Signals Openness to Chinese Automakers if US Trade Talks Fail
-
Canada Expands Asian Trade Push as US Negotiations Resume
US court rules distributors not responsible for opioid crisis
The three largest drug distributors in the United States have won a major court victory, with a judge ruling that they were not responsible for record opioid addiction in one part of West Virginia state.
About 10 percent of Cabell County's population is or has been addicted to opioids -- at a huge economic and social cost, acknowledged Judge David Faber.
But "while there is a natural tendency to assign blame in such cases, they must be decided not based on sympathy, but on the facts and the law," he wrote in a decision released Monday night.
The "plaintiffs failed to show that the volume of prescription opioids distributed in Cabell/Huntington was because of unreasonable conduct" by defendants AmerisourceBergen, Cardinal Health and McKesson, Faber wrote.
Tasked with supplying pharmacies, the three firms delivered more than 51 million doses of pain medication in the county between 2006 and 2014, and local authorities accused them of turning a blind eye to suspicious order volumes.
But "there is nothing unreasonable about distributing controlled substances to fulfill legally written prescriptions," Faber said.
He put the blame on manufacturers who "aggressively market prescription opioids," rather than the companies that distributed them.
After becoming addicted to pain pills, many people increased their consumption and eventually turned to illicit drugs such as heroin and fentanyl, an extremely powerful synthetic opioid.
The opioid crisis, which has caused more than 500,000 deaths over 20 years in the United States, has triggered a flurry of lawsuits from victims as well as cities, counties and states impacted by the fallout.
The suit filed by Cabell County and the city of Huntington had become a symbol of authorities' efforts to make companies pay for the social and economic cost of the crisis.
Between May 3 and July 28, 2021, 70 witnesses testified as part of the lawsuit in federal court in Charleston, West Virginia.
While the hearings were still ongoing, the three distributors and pharmaceutical company Johnson & Johnson agreed to pay $26 billion to end a series of legal actions in a settlement that is still being finalized.
H.Seidel--BTB